Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties

Vera Levina, Adele M. Marrangoni, Richard DeMarco et al. · 2008

Read Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties by Vera Levina, Adele M. Marrangoni, Richard DeMarco et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003077.txt.

Description

Vera Levina, Adele Marrangoni, Richard DeMarco and co-authors enriched lung cancer stem cells with drug selection in 2008. Cancer stem cells are thought to regrow tumors after chemotherapy, though direct confirmation was still forthcoming. The team asked whether drug treatment could enrich and maintain such cells.

They then examined the enriched cells' cytokine network plus tumor-forming and metastatic properties. Published in PLOS ONE, drug-selected cells model the survivors that relapse is made of. Studying them is a step toward treatments aimed at the cells chemotherapy leaves behind. Full methods, data, and references appear in the complete article for readers who want more detail.

Catalog record

CREATORVera Levina, Adele M. Marrangoni, Richard DeMarco et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003077

Browse the full library · About the Tower of Babel